XML Financial LLC lessened its position in iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 8.3% during the 2nd quarter, HoldingsChannel.com reports. The fund owned 2,767 shares of the financial services provider’s stock after selling 251 shares during the period. XML Financial LLC’s holdings in iShares Biotechnology ETF were worth $380,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other institutional investors and hedge funds also recently made changes to their positions in IBB. International Assets Investment Management LLC bought a new position in shares of iShares Biotechnology ETF during the 4th quarter worth about $563,000. Tennessee Valley Asset Management Partners bought a new position in shares of iShares Biotechnology ETF during the 4th quarter worth about $44,000. Calamos Advisors LLC bought a new position in shares of iShares Biotechnology ETF during the 4th quarter worth about $7,648,000. abrdn plc bought a new position in shares of iShares Biotechnology ETF during the 4th quarter worth about $5,928,000. Finally, Signaturefd LLC boosted its position in shares of iShares Biotechnology ETF by 14.2% during the 4th quarter. Signaturefd LLC now owns 1,120 shares of the financial services provider’s stock valued at $152,000 after acquiring an additional 139 shares in the last quarter. Institutional investors own 62.45% of the company’s stock.
iShares Biotechnology ETF Price Performance
Shares of iShares Biotechnology ETF stock traded up $0.77 during trading on Wednesday, hitting $148.15. 751,839 shares of the company’s stock traded hands, compared to its average volume of 1,580,583. The firm’s fifty day moving average price is $141.56 and its 200 day moving average price is $136.94. iShares Biotechnology ETF has a twelve month low of $111.83 and a twelve month high of $150.17.
iShares Biotechnology ETF Profile
iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.
Recommended Stories
- Five stocks we like better than iShares Biotechnology ETF
- The How And Why of Investing in Oil Stocks
- Target Hits the Mark: Q2 Earnings Exceed Expectations
- What is a Death Cross in Stocks?
- Is Tesla’s Rebound Just Starting? Why You Should Consider Buying
- What is the Australian Securities Exchange (ASX)
- Stanley Druckenmiller’s Latest Bet: MELI—Should You Follow Suit?
Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Biotechnology ETF (NASDAQ:IBB – Free Report).
Receive News & Ratings for iShares Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.